On-site monitoring of clinical trials by an Ethics Committee in India: a road less travelled

被引:5
作者
Shafiq, Nusrat [1 ]
Kumari, Savita [2 ]
Kumar, Vivek [3 ]
Suri, Vinita [4 ]
Jayashree, Muralidharan [5 ]
Duseja, Ajay [6 ]
Bansal, Arun [7 ]
Malhotra, Samir [1 ]
机构
[1] Postgrad Inst Med Educ & Res, Dept Pharmacol, Room 4001,4th Floor,Res Block B, Chandigarh 160012, India
[2] Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh, India
[3] Postgrad Inst Med Educ & Res, Dept Nephrol, Chandigarh, India
[4] Postgrad Inst Med Educ & Res, Dept Obstet & Gynaecol, Chandigarh, India
[5] Postgrad Inst Med Educ & Res, Adv Pediat Ctr, Dept Pediat, Chandigarh, India
[6] Postgrad Inst Med Educ & Res, Dept Hepatol, Chandigarh, India
[7] Postgrad Inst Med Educ & Res, Dept Pediat Med, Chandigarh, India
关键词
Ethics Committee; on-site monitoring; good clinical practice; India;
D O I
10.1177/1747016120933923
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
Monitoring of clinical trials is important to ensure adherence to protocol, to safeguard the rights of research participants and to achieve compliance with principles of good clinical practice. Recent regulatory changes in India require Ethics Committees to keep an oversight of ongoing clinical trials including on-site monitoring. In this article, we share the experience of on-site monitoring of clinical trials by the Ethics Committee of a tertiary care, academic and research centre in India. We found a large number of shortcomings in the areas of informed consent, adverse events, insurance and reimbursement, which would not have been detected by off-site document review. Interestingly, many shortcomings were also not detected by on-site monitoring arranged by clinical trial sponsors. We therefore conclude that on-site monitoring of ongoing clinical trials is a highly important activity for Indian Ethics Committees.
引用
收藏
页码:45 / 54
页数:10
相关论文
共 9 条
  • [1] Rare cancers in India: A road less travelled
    Darling, H. S.
    Rastogi, Sameer
    INDIAN JOURNAL OF CANCER, 2020, 57 (02) : 139 - 143
  • [2] Regulating clinical trials in India: The economics of ethics
    Porter, Gerard
    DEVELOPING WORLD BIOETHICS, 2018, 18 (04) : 365 - 374
  • [3] How to get ethics committee approval for clinical trials in Turkey?
    Ilbars, Hilal
    Bebitoglu, Berna Terzioglu
    NORTHERN CLINICS OF ISTANBUL, 2018, 5 (04) : 379 - 386
  • [4] Evaluation of clinical trials following an approval from a research ethics committee
    Menzel, S.
    Uebing, B.
    Hucklenbroich, P.
    Schober, O.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2007, 132 (44) : 2313 - 2317
  • [5] Academic Clinical Trials Submitted to an Institutional Ethics Committee at a Tertiary Care Center: A Retrospective Analysis
    Shetty, Yashashri C.
    Aithal, Yashoda R.
    Katkar, Janhavi
    Naik, Manali
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [6] Reducing Clinical Trial Monitoring Resources and Costs With Remote Monitoring: Retrospective Study Comparing On-Site Versus Hybrid Monitoring
    Fu, Zhiying
    Liu, Xiaohong
    Zhao, Shuhua
    Yuan, Yannan
    Jiang, Min
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2023, 25
  • [7] Non-commercial vs. commercial clinical trials: a retrospective study of the applications submitted to a research ethics committee
    Fuentes Camps, Inmaculada
    Rodriguez, Alexis
    Agusti, Antonia
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (06) : 1384 - 1388
  • [8] Assessing the potential for prevention or earlier detection of on-site monitoring findings from randomised controlled trials: Further analyses of findings from the prospective TEMPER triggered monitoring study
    Cragg, William J.
    Hurley, Caroline
    Yorke-Edwards, Victoria
    Stenning, Sally P.
    CLINICAL TRIALS, 2021, 18 (01) : 115 - 126
  • [9] Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: A scoping review
    Cragg, William J.
    Hurley, Caroline
    Yorke-Edwards, Victoria
    Stenning, Sally P.
    CLINICAL TRIALS, 2021, 18 (02) : 245 - 259